News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Roche Takeover Target After Family Loses Majority Stake?
March 28, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
pharmatimes.com -- Media speculation that Roche may be vulnerable to takeover attempts has been growing over the weekend after the family group at the helm lost its majority stake in the firm.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Roche
MORE ON THIS TOPIC
Mergers & acquisitions
Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking
October 20, 2025
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
October 17, 2025
·
2 min read
·
Tristan Manalac
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
·
2 min read
·
Dan Samorodnitsky
